| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/05/1995 | CA2165786A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 01/05/1995 | CA2165559A1 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | CA2164955A1 Method for treating hyperkeratosis and diseases mediated by proteases |
| 01/04/1995 | EP0632129A1 Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 01/04/1995 | EP0631624A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 01/04/1995 | EP0631580A1 PYRIDO 2,3-d]PYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS |
| 01/04/1995 | EP0631502A1 Lymphocyte activity regulation by hla peptides |
| 01/04/1995 | EP0470231B1 Composition and use of the composition for the manufacture of a medicament for the treatment of injuries caused by the radiation of heat and light |
| 01/03/1995 | US5378825 Backbone modified oligonucleotide analogs |
| 01/03/1995 | US5378823 Trophoblastin |
| 01/03/1995 | US5378811 Pure C3b inactivator and a process for producing said protein |
| 01/03/1995 | US5378699 Treatment of immune diseases, cell proliferation, restenosis and smooth muscle cells |
| 01/03/1995 | US5378464 Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140 |
| 01/03/1995 | CA2027394C 3-substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis |
| 01/03/1995 | CA1333803C .alpha.-substituted 4-(quinolin-2-yl-methoxy)phenylacetic acids and esters |
| 01/03/1995 | CA1333802C Substituted 4-(quinolin-2-yl-methoxy)phenyl-acetic acid derivatives |
| 01/03/1995 | CA1333801C Heterazole dialkanoic acids |
| 01/03/1995 | CA1333771C Use of imexon as an immune suppressive and pharmaceutical compositions containing them |
| 12/28/1994 | EP0630889A1 Pharmacologically active derivatives of 2-(benzimidazol-2-yl)-1,3-diaminopropane |
| 12/28/1994 | EP0630384A1 Methods and compounds for prevention of graft rejection |
| 12/28/1994 | EP0630257A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 12/28/1994 | EP0630255A1 Mhc conjugates useful in ameliorating autoimmunity |
| 12/28/1994 | EP0630252A1 Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections |
| 12/28/1994 | EP0630245A1 Protein kinase c inhibitor |
| 12/28/1994 | EP0630241A1 Indole derivatives with antiviral activity |
| 12/28/1994 | EP0630232A1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor |
| 12/28/1994 | EP0617705A4 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them. |
| 12/28/1994 | CN1096781A Therapeutic agents |
| 12/27/1994 | US5376681 Aminocoumaran derivatives, their production and use |
| 12/27/1994 | US5376680 Oxime derivatives |
| 12/27/1994 | US5376667 Derivatives of benzoylecgonine, ecgonine and their multiple pharmacological properties |
| 12/27/1994 | US5376546 Analogs of ribosome-inactivating proteins |
| 12/27/1994 | US5376367 Fusion proteins comprising MGF and IL-3 |
| 12/27/1994 | US5375693 Methods and compositions for treating allergic disorders and other disorders metabolic derivatives of terfenadine |
| 12/27/1994 | CA1333714C Quinoline ether alkanoic acids for use as inhibitors of leukotriene biosynthesis |
| 12/22/1994 | WO1994029727A1 Inhibiting protein interactions |
| 12/22/1994 | WO1994029459A1 Stress proteins and uses therefor |
| 12/22/1994 | WO1994029451A2 Humanised antibodies |
| 12/22/1994 | WO1994029299A1 Imidazole lipoxygenase inhibitors |
| 12/22/1994 | WO1994029297A1 2-oxo-1,2,3,4-tetrahydroquinoline derivatives |
| 12/22/1994 | WO1994029295A1 Heterocyclic derivatives with immunomodulating activity |
| 12/22/1994 | WO1994029291A1 Aniline derivatives |
| 12/22/1994 | WO1994029262A1 Lipoxin compounds |
| 12/22/1994 | WO1994028916A1 Release and mobilisation of haematopoietic cells |
| 12/22/1994 | WO1994028910A1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
| 12/22/1994 | WO1994028895A2 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 12/22/1994 | WO1994028870A1 Preparations containing silicon dioxide to improve the taste thereof |
| 12/22/1994 | WO1994025588A3 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β) |
| 12/22/1994 | WO1994017773A3 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 12/22/1994 | CA2164827A1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose |
| 12/22/1994 | CA2164298A1 Stress proteins and uses therefor |
| 12/22/1994 | CA2163905A1 Inhibiting protein interactions |
| 12/22/1994 | CA2163344A1 Humanised antibodies |
| 12/22/1994 | CA2160368A1 Preparations containing silicon dioxide to improve the taste thereof |
| 12/22/1994 | CA2140660A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 12/21/1994 | EP0629635A1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them |
| 12/21/1994 | EP0629406A1 Medicament for the treatment of sepsis or septic shock |
| 12/21/1994 | EP0629350A1 Milk protein hydrolysates |
| 12/21/1994 | EP0629213A1 Immunostimulatory agent. |
| 12/21/1994 | EP0629208A1 Fluorosugar derivatives of macrolides |
| 12/21/1994 | EP0629203A1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents |
| 12/21/1994 | EP0629130A1 Use of interleukin-10 to suppress graft-vs.-host disease |
| 12/21/1994 | CN1096515A New peptides |
| 12/21/1994 | CN1027068C Alpha-substituted 4-(quinolin-2-yl-methoxy)-phenylacetic acide and-esters |
| 12/21/1994 | CN1027065C Tetralin esters of phenols or benzoic acids |
| 12/20/1994 | US5374772 Substituted benzoic acids, inhibitors of phospholipases A2 |
| 12/20/1994 | US5374647 Antithrombotic substituted cycloalkano (B) dihydroindole sulphonamides |
| 12/20/1994 | US5374629 Vitamin D analogues |
| 12/20/1994 | CA1333606C Substituted 2-phenyl-4-quinoline carboxylic acids |
| 12/20/1994 | CA1333571C Preventing agent for human immunodeficiency virus infection comprising menfegol |
| 12/20/1994 | CA1333569C Method of treatment for autoimmune diseases |
| 12/20/1994 | CA1333563C Synthetic vaccine against foot and mouth disease and a process for the preparation thereof |
| 12/18/1994 | CA2126158A1 19-nor steroids phenoxyalkylsulfonamide or phenoxyalkylsulfonylurea chain on 11 beta position, process and intermediates for their preparation, application as medicaments and pharmaceutical compositions containing them |
| 12/17/1994 | CA2125793A1 Organic compounds |
| 12/15/1994 | CA2125725A1 Urea derivative containing heterocyclic ring |
| 12/14/1994 | EP0628551A1 Semicyclic urea derivatives as antihistaminic agents |
| 12/14/1994 | EP0628074A1 $i(IN VITRO) ACTIVATION OF CYTOTOXIC T CELLS |
| 12/14/1994 | EP0628056A1 Directed human immune globulin for the prevention and treatment of staphylococcal infections |
| 12/14/1994 | EP0628053A1 Hepatitis e virus peptide antigens and antibodies |
| 12/14/1994 | EP0628032A1 Quinazolinone antianginal agents |
| 12/14/1994 | EP0627934A1 Early antigen for autoimmune diabetes |
| 12/14/1994 | EP0627933A1 Bystander suppression of autoimmune diseases |
| 12/14/1994 | EP0543864B1 Novel vitamin d analogues |
| 12/14/1994 | EP0382840B1 Aloe compositions and uses thereof |
| 12/13/1994 | US5373093 Suitable in preparation of reproter molecules and for magnetic resonance, radiation imaging and and radiation therapy |
| 12/13/1994 | US5373007 Pyridooxazinyl or pyridothiazinyl as inhibitors of leukotrienes |
| 12/13/1994 | US5372933 Antibody-polypeptide immunocomplex |
| 12/13/1994 | CA1333471C Whey protein concentrate as food supplement |
| 12/08/1994 | WO1994028153A2 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
| 12/08/1994 | WO1994028132A2 Opioid receptors: compositions and methods |
| 12/08/1994 | WO1994028027A1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
| 12/08/1994 | WO1994027998A1 Psoralen®* derivatives, their preparation and use |
| 12/08/1994 | WO1994027968A1 Quinoline derivatives as leukotriene antagonists |
| 12/08/1994 | WO1994027634A1 Cryptic peptides for use in inducing immunologic tolerance |
| 12/08/1994 | WO1994027622A1 Surrogate tolerogenesis for the development of tolerance to xenografts |
| 12/08/1994 | WO1994027614A1 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis |
| 12/08/1994 | WO1994027609A1 Dihydrotestosterone for use in androgenotherapy |
| 12/08/1994 | WO1994027435A1 Genetic immunization with cationic lipids |
| 12/08/1994 | WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 12/08/1994 | WO1994012165A3 Enzyme inhibitors |